{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:31:48Z","timestamp":1793759508912,"version":"4.6.1"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,5,1]]},"DOI":"10.1359\/jbmr.1997.12.5.856","type":"journal-article","created":{"date-parts":[[2006,4,26]],"date-time":"2006-04-26T22:28:51Z","timestamp":1146090531000},"page":"856-862","source":"Crossref","is-referenced-by-count":63,"title":["Primary Hyperparathyroidism: Still Evolving?"],"prefix":"10.1093","volume":"12","author":[{"given":"Shonni J.","family":"Silverberg","sequence":"first","affiliation":[{"name":"Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York, U.S.A."},{"name":"Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024020713144065100_bib1","volume-title":"The Parathyroid Glands and Metabolic Bone Disease","author":"Albright","year":"1948"},{"key":"2024020713144065100_bib2","first-page":"135","article-title":"Hyperparathyroidism: Distinct disease entity","volume":"15","author":"Bauer","year":"1933","journal-title":"J Bone Joint Surg"},{"key":"2024020713144065100_bib3","first-page":"S25","article-title":"Epidemiology of primary hyperparathyroidism","author":"Melton","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2024020713144065100_bib4","first-page":"757","volume-title":"Principles of Bone Biology","author":"Hendy","year":"1996"},{"key":"2024020713144065100_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.1991.tb03514.x","article-title":"Cell kinetics in parathyroid adenomas: Evidence for decline in rates of cell birth and tumor growth, assuming clonal origin","volume":"35","author":"Parfitt","year":"1991","journal-title":"Clin Endocrinol"},{"key":"2024020713144065100_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJM198803173181102","article-title":"Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas","volume":"318","author":"Arnold","year":"1988","journal-title":"New Engl J Med"},{"key":"2024020713144065100_bib7","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1172\/JCI114114","article-title":"Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma","volume":"83","author":"Arnold","year":"1989","journal-title":"J Clin Invest"},{"key":"2024020713144065100_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/jcem-71-2-293","article-title":"Genetic abnormalities in sporadic parathyroid adenoma","volume":"71","author":"Friedman","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1210\/jcem-69-3-496","article-title":"Clonal loss of one chromosome 11 in a parathyroid adenoma","volume":"69","author":"Arnold","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/gcc.2870130103","article-title":"Frequent loss of chromosome arm 1p in parathyroid adenomas","volume":"13","author":"Cryns","year":"1995","journal-title":"Genes Chrom Cancer"},{"key":"2024020713144065100_bib11","first-page":"373","volume-title":"The Parathyroids","author":"Parfitt","year":"1994"},{"key":"2024020713144065100_bib12","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"key":"2024020713144065100_bib13","first-page":"3584","article-title":"Hypercalcemia due to constitutive activity of the parathyroid hormone\/PTH-related peptide receptor: Comparison with primary hyperparathyroidism","volume":"81","author":"Parfitt","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"New Engl J Med"},{"key":"2024020713144065100_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00060793-199612000-00013","article-title":"Molecular genetics of parathyroid disease","volume":"3","author":"Thakker","year":"1996","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"2024020713144065100_bib16","first-page":"3107","article-title":"The extracellular calcium-sensing receptor gene in human parathyroid tumors","volume":"80","author":"Hosokawa","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib17","first-page":"3377","article-title":"Genetic abnormalities in sporadic parathyroid adenomas: Loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus","volume":"80","author":"Thompson","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJM198907273210403","article-title":"Association of parathyroid tumors in multiple endocrine neoplasia type I with loss of alleles on chromosome 11","volume":"32","author":"Thakker","year":"1989","journal-title":"New Engl J Med"},{"key":"2024020713144065100_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJM198907273210402","article-title":"Clonality of parathyroid tumors in familial multiple endocrine neoplasia type I","volume":"321","author":"Friedman","year":"1989","journal-title":"New Engl J Med"},{"key":"2024020713144065100_bib20","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI117890","article-title":"Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia","volume":"95","author":"Arnold","year":"1995","journal-title":"J Clin Invest"},{"key":"2024020713144065100_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9343(89)80613-8","article-title":"Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism","volume":"87","author":"Turken","year":"1989","journal-title":"Am J Med"},{"key":"2024020713144065100_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9343(94)90127-9","article-title":"Parathyroidectomy for non-traditional features of primary hyperparathyroidism","volume":"96","author":"Kleerekoper","year":"1994","journal-title":"Am J Med"},{"key":"2024020713144065100_bib23","first-page":"512","volume-title":"Principles and Practice of Endocrinology and Metabolism","author":"Silverberg","year":"1995"},{"key":"2024020713144065100_bib24","first-page":"690","article-title":"Anabolic actions of parathyroid hormone on bone","volume":"14","author":"Dempster","year":"1993","journal-title":"Endocrinol Rev"},{"key":"2024020713144065100_bib25","first-page":"481","article-title":"Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism","volume":"74","author":"Seibel","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib26","first-page":"A624","article-title":"Bone alkaline phosphatase in primary hyperparathyroidism","volume":"6","author":"Silverberg","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2024020713144065100_bib27","first-page":"1","article-title":"Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: Effects of sex, age, and metabolic bone disease","volume":"5","author":"Duda","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02411221","article-title":"Changes in plasma bone Gla-protein during treatment of bone disease","volume":"34","author":"Deftos","year":"1982","journal-title":"Calcif Tissue Int"},{"key":"2024020713144065100_bib29","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/clinchem\/37.7.1143","article-title":"Bone protein and peptide assays in the diagnosis and management of skeletal disease","volume":"37","author":"Deftos","year":"1991","journal-title":"Clin Chem"},{"key":"2024020713144065100_bib30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1210\/jcem-71-2-442","article-title":"Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase","volume":"71","author":"Kraenzlin","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib31","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00060793-199612000-00012","article-title":"Primary hyperparathyroidism: Usefulness of bone mass measurements","volume":"3","author":"Bilezikian","year":"1996","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"2024020713144065100_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2024020713144065100_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-3-642-70709-4_25","volume-title":"Current concepts of bone fragility","author":"Parfitt","year":"1986"},{"key":"2024020713144065100_bib34","first-page":"7","volume-title":"Clinical Disorders of Bone and Mineral Metabolism","author":"Parfitt","year":"1989"},{"key":"2024020713144065100_bib35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histormorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure","volume":"70","author":"Parisien","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib36","first-page":"N36","article-title":"Bone histomorphometry and serum intact PTH(1\u201384) in hyperparathyroid patients","volume":"44S","author":"van Doorn","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"2024020713144065100_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/8756-3282(92)90360-9","article-title":"Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods","volume":"13","author":"Christiansen","year":"1992","journal-title":"Bone"},{"key":"2024020713144065100_bib38","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/jbmr.5650100917","article-title":"Bone structure in postmenopausal hyperparathyroid, osteoporotic and normal women","volume":"10","author":"Parisien","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2024020713144065100_bib39","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: Biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocrinol Rev"},{"key":"2024020713144065100_bib40","first-page":"3450","article-title":"Circulating levels of IL-6 and TNF-a are elevated in primary hyperparathyroidism and correlate with markers of bone resorption","volume":"81","author":"Grey","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib41","first-page":"s9","article-title":"Consensus development conference statement on primary hyperparathyroidism","volume":"6","author":"National Institutes of Health","year":"1991","journal-title":"J Bone Miner Metab"},{"key":"2024020713144065100_bib42","first-page":"531","volume-title":"The Parathyroids: Basic and Clinical Concepts","author":"Norton","year":"1994"},{"key":"2024020713144065100_bib43","first-page":"77","article-title":"Preoperative localization of parathyroid tissue with technetium-99m sestamibi 123-I subtraction scanning","volume":"78","author":"Thule","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib44","first-page":"346","article-title":"The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging","volume":"81","author":"Johnston","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib45","first-page":"729","article-title":"Increased bone mineral density following parathyroidectomy in primary hyperparathyroidism","volume":"80","author":"Silverberg","year":"1995","journal-title":"J Clin Metab"},{"key":"2024020713144065100_bib46","first-page":"241","article-title":"The effect of parathyroidectomy on the recurrence of nephrolithiasis","volume":"215","author":"Deaconson","year":"1987","journal-title":"Surgery"},{"key":"2024020713144065100_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1210\/jcem-42-3-415","article-title":"Metabolic effects of parathyroidectomy in asymptomatic primary hyperparathyroidism","volume":"42","author":"Kaplan","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-5347(17)55922-4","article-title":"The effect of parathyroidectomy in patients with normocalcemic calcium stones","volume":"123","author":"Siminovich","year":"1980","journal-title":"J Urol"},{"key":"2024020713144065100_bib49","first-page":"4007","article-title":"Vertebral osteopenia: A new indication for surgery in primary hyperparathyroidism","volume":"81","author":"Silverberg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib50","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","article-title":"Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism","volume":"67","author":"Rao","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib51","first-page":"s97","article-title":"Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: Clinical course and considerations bearing on the need for surgical intervention","author":"Parfitt","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2024020713144065100_bib52","first-page":"723","article-title":"Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism","volume":"80","author":"Silverberg","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib53","first-page":"941","article-title":"Lethal hyperparathyroid crisis: Hazards of phosphate administration","volume":"102","author":"Vernava","year":"1987","journal-title":"Surgery"},{"key":"2024020713144065100_bib54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-100-5-633","article-title":"Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism","volume":"100","author":"Marcus","year":"1984","journal-title":"Ann Intern Med"},{"key":"2024020713144065100_bib55","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1002\/jbmr.5650061426","article-title":"Estrogens and progestins in the management of primary hyperparathyroidism","author":"Marcus","year":"1991","journal-title":"J Bone Mineral Res"},{"key":"2024020713144065100_bib56","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJM198606053142304","article-title":"Ethinyl estradiol and norethinedrone in the treatment of primary hyperparathyroidism in postmenopausal women","volume":"314","author":"Selby","year":"1986","journal-title":"New Engl J Med"},{"key":"2024020713144065100_bib57","first-page":"519","volume-title":"The Parathyroids: Basic and Clinical Concepts","author":"Stock","year":"1994"},{"key":"2024020713144065100_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4158\/EP.3.1.22","article-title":"Primary hyperparathyroidism: Diagnosis and management","volume":"3","author":"Khan","year":"1997","journal-title":"Endocrinol Practice"},{"key":"2024020713144065100_bib59","first-page":"1067","article-title":"Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with residronate","volume":"77","author":"Reasner","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713144065100_bib60","first-page":"S181","article-title":"A first generation calcimimetic compound (NPS R-568) that acts on the parathyroid cell calcium receptor: A novel therapeutic approach for hyperparathyroidism","volume":"8","author":"Fox","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024020713144065100_bib61","first-page":"87A","article-title":"The effect of the calcimimetic drug NPS R-568 on parathyroid hormone secretion in primary hyperparathyroidism","author":"Silverberg","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024020713144065100_bib62","author":"Locker","year":"1997"},{"key":"2024020713144065100_bib63","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1001\/jama.1994.03520240070044","article-title":"Optimal calcium intake: statement of the consensus development panel on optimal calcium intake","volume":"272","author":"Bilezikian","year":"1994","journal-title":"J Amer Med Assoc"},{"key":"2024020713144065100_bib64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism: Incidence, morbidity, and economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N Engl J Med"},{"key":"2024020713144065100_bib65","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(80)91783-3","article-title":"Primary hyperparathyroidism: Changes in the pattern of clinical presentation","volume":"1","author":"Mundy","year":"1980","journal-title":"Lancet"},{"key":"2024020713144065100_bib66","first-page":"473","article-title":"Asymptomatic primary hyperparathyroidism","volume":"56","author":"Scholz","year":"1981","journal-title":"Mayo Clin Proc"},{"key":"2024020713144065100_bib67","first-page":"457","volume-title":"The Parathyroids: Basic and Clinical Concepts","author":"Bilezikian","year":"1994"},{"key":"2024020713144065100_bib68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-126-6-199703150-00003","article-title":"The rise and fall of primary hyperparathyroidism: A population based study in Rochester, MN 1965\u20131992","volume":"126","author":"Wermers","year":"1997","journal-title":"Ann Intern Med"},{"key":"2024020713144065100_bib69","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1995.tb02043.x","article-title":"Vitamin D status in primary hyperparathyroidism in India","volume":"43","author":"Harinarayan","year":"1995","journal-title":"Clin Endocrinol"},{"key":"2024020713144065100_bib70","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4158\/EP.2.4.250","article-title":"Coexisting hyperthyroidism and hyperparathyroidism with vitamin D deficient osteomalacia in a Vietnamese immigrant","volume":"2","author":"Luong","year":"1996","journal-title":"Endocrinol Practice"},{"key":"2024020713144065100_bib71","first-page":"13","article-title":"The diagnosis of primary hyperparathyroidism- analysis of 134 cases","volume":"16","author":"Meng","year":"1994","journal-title":"Acta Acad Med Sinicae"},{"key":"2024020713144065100_bib72","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(71)91333-X","article-title":"Vitamin D deficiency and primary hyperparathyroidism","volume":"2","author":"Woodhouse","year":"1971","journal-title":"Lancet"},{"key":"2024020713144065100_bib73","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0002-9343(74)90812-2","article-title":"Parathyroid function in vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism","volume":"54","author":"Lumb","year":"1974","journal-title":"Am J Med"},{"key":"2024020713144065100_bib74","first-page":"161","volume-title":"Osteoporosis: Etiology, Diagnosis and Management","author":"Blumsohn","year":"1995","edition":"2nd Ed."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.1997.12.5.856","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/12\/5\/856\/56596418\/5650120520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/12\/5\/856\/56596418\/5650120520.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:55:06Z","timestamp":1710341706000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/12\/5\/856-862\/7514223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5,1]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[1997,5,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.1997.12.5.856","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1997,5,1]]},"published":{"date-parts":[[1997,5,1]]}}}